Department of Physical Medicine and Rehabilitation, Jeonbuk National University Medical School, Jeonju, Korea.
Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea.
J Back Musculoskelet Rehabil. 2022;35(6):1381-1389. doi: 10.3233/BMR-210357.
While a number of preclinical studies have examined the effectiveness of low-intensity pulsed ultrasound (LIPUS) as a potential treatment for knee osteoarthritis (OA), there have been few clinical studies which have indirectly confirmed cartilage regeneration by magnetic resonance imaging (MRI).
The aim of this clinical trial was to investigate whether LIPUS effectively increased knee cartilage thickness and improved pain and function in knee OA patients.
This study was a prospective, single-group, home-based self-therapy trial. We included patients (n= 20) with OA pain. Each patient used an ultrasonic stimulation device (BODITREK JOINT™) for more than 20 sessions. Outcomes were assessed by MRI, Visual Analogue Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the 36-Item Short Form Survey (SF-36) for assessing quality of life.
Nineteen subjects completed this study. There was no significant increase in the cartilage thickness measured by MRI after LIPUS treatment. LIPUS therapy significantly decreased VAS score and WOMAC score, and significantly increased SF-36 score. The subgroup analysis in patients with knee OA showed that LIPUS treatment showed better for older patients with lower Kellgren-Lawrence grades.
Pain, function, and quality of life improved after LIPUS, but there was no significant increase in cartilage thickness through MRI.
虽然许多临床前研究已经研究了低强度脉冲超声(LIPUS)作为治疗膝骨关节炎(OA)的潜在疗法的有效性,但很少有临床研究通过磁共振成像(MRI)间接证实软骨再生。
本临床试验旨在探讨 LIPUS 是否能有效增加膝软骨厚度,并改善膝 OA 患者的疼痛和功能。
本研究为前瞻性、单组、家庭自助治疗试验。我们纳入了(n=20)有 OA 疼痛的患者。每位患者使用超声刺激设备(BODITREK JOINT™)超过 20 次。通过 MRI、视觉模拟量表(VAS)、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)和 36 项简短调查问卷(SF-36)评估生活质量来评估结果。
19 名受试者完成了这项研究。LIPUS 治疗后 MRI 测量的软骨厚度没有显著增加。LIPUS 治疗显著降低了 VAS 评分和 WOMAC 评分,显著增加了 SF-36 评分。在膝骨关节炎患者的亚组分析中,LIPUS 治疗对较低 Kellgren-Lawrence 分级的老年患者效果更好。
LIPUS 治疗后疼痛、功能和生活质量得到改善,但 MRI 显示软骨厚度没有显著增加。